Change theme to redChange theme to blueChange theme to greenChoose your color
Last Modified Date: 17 Jan 2013
  • |
  • Printer Friendly
  • |
  • Download Adobe Reader
  • |
  • Small Font
  • Medium Font
  • Large Font
Marketing Materials
 
 
Home
Technologies Available for Licensing

Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil


SKIN-ACTIVE ADJUVANTS FOR TRANSCUTANEOUS IMMUNIZATION

GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: 1wherein R.sub.1a, R.sub.1b, R.sub.1c, R.sub.2a, R.sub.2b, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.

Number:2006-0002959

Application:11/109,948

Date:2006-01-05

Type: Pending

Category: Vaccine

More Detail:Visit USPTO.GOVExternal link

For Licensing Opportunities, please contact the ORTA at USAMRMCORTA@amedd.army.mil
 
 

iSalute

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRMC Public Affairs Office at:
usamrmcwebmaster@amedd.army.mil or by telephone at (301)619-2736